MICHAEL STROBEL: Open Payments
NPI 1356828420 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 16 payments from 11 companies in 2025. Trend: 2023 $146 · 2024 $336 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| PFIZER INC. | 2 | $47 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Boston Scientific Corporation | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: LEQVIO, ELIQUIS, ONPATTRO, Ozempic, FARXIGA, JARDIANCE, WATCHMAN, CAPVAXIVE.
Industry payments across NY — which companies pay providers there.
